Clinical Trials Browser

INDUSTRY × Expanded_access × Myasthenia Gravis × Clear all

NCT04777734 2022-04-29

Efgartigimod Expanded Access for Generalized Myasthenia Gravis

Approved for marketing

Myasthenia Gravis